Asana BioSciences
11 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate ASN008 Topical Gel (TG) (NCT03798561) | Asana BioSciences | 2019-01-14 |
| Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema (NCT03728504) | Asana BioSciences | 2019-01-03 |
| Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects (NCT03641573) | Asana BioSciences | 2018-10-11 |
| Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (NCT03654755) | Asana BioSciences | 2018-09-29 |
| Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT) (NCT03531957) | Asana BioSciences | 2018-07-05 |
| A Study of ASN007 in Patients With Advanced Solid Tumors (NCT03415126) | Asana BioSciences | 2018-01-19 |
Track Asana BioSciences automatically
Every clearance here is in the API, with alerts when new ones post.